NFKB1 and atherosclerosis: EV-miR-182 and EV-miR-let7 derived from MSCs can improve the progression of inflammation by inhibiting the NF-κB pathway in myocardial ischemia-reperfusion injury, atherosclerosis and skin inflammation.